Table 2.
The pooled ORs and 95%CIs for the association between LAPTM4B polymorphism and cancer susceptibility
| Models | No. of studies | No. of population (case/control) | OR | 95%CI | P | P(H) | P(P) |
|---|---|---|---|---|---|---|---|
| *2 vs *1 | 18 | 4556/4584 | 1.487 | 1.339-1.651 | <0.001 | <0.001 | 0.667 |
| *1/2 vs *1/1 | 17 | 4454/4449 | 1.550 | 1.367-1.758 | <0.001 | 0.004 | 0.759 |
| *2/2 vs *1/1 | 17 | 4454/4449 | 2.093 | 1.666-2.629 | <0.001 | 0.005 | 0.099 |
| *1/2 + *2/2 vs *1/1 | 17 | 4454/4449 | 1.806 | 1.527-2.137 | <0.001 | <0.001 | 0.564 |
| *2/2 vs *1/2 + *1/1 | 17 | 4454/4449 | 1.714 | 1.408-2.088 | <0.001 | 0.034 | 0.064 |
*P(H): P-value for test of heterogeneity, P(P): P value for test of publication bias.